FDA concedes SOBI’s IND application for SOBI003 along with Fast Track Status for treating MPS IIIA Read more
Evofem Biosciences enrolls first patient in Phase 2b/3 Clinical Trial assessing Amphora’s ability to foil UCG in women Read more
ProMIS Neurosciences claimed further results of previously claimed Preclinical program for Alzheimer’s Disease Read more